Megna Michael R Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$1.02M

Insider Activity of Megna Michael R

According to the SEC Form 4 filings, Megna Michael R, being in a position of

  1. CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals International, plc,
    оver the last 12 months, has bought 0 shares, and sold 47485 shares for $4.1M,
    over all time since 2023-12-19, has bought 0 shares, and sold 208664 shares for $8.93M.

Biography of Megna Michael R

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$4,102,7933100

Comparison of Insiders on Amount of Buys and Sells

2026-10-30SaleKiniksa Pharmaceuticals International, plc
KNSA
CHIEF ACCOUNTING OFFICER
36,260
0.0475%
$94.43$3.42M
2026-09-03SaleKiniksa Pharmaceuticals International, plc
KNSA
CHIEF ACCOUNTING OFFICER
4,600
0.006%
$80.30$369,380-3.09%
2026-04-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
6,625
0.0085%
$46.69$309,321+37.48%
2025-10-20SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
50,490
0.0679%
$38.87$1.96M+22.72%
2025-09-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
11,000
0.0146%
$34.84$383,240+27.8%
2025-08-04SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
17,000
0.0232%
$32.35$549,950+31.08%
2025-06-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
15,211
0.0206%
$28.75$437,316+40.85%
2025-05-07SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
17,647
0.0241%
$26.69$470,998+45.42%
2025-03-12SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
9,051
0.0124%
$22.45$203,195+58.98%
2024-11-29SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
9
<0.0001%
$22.45$202+23.46%
2024-03-01SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
9,659
0.0136%
$21.45$207,186-6.62%
2024-02-28SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
5,126
0.0078%
$21.79$111,696-0.25%
2024-01-02SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
16,670
0.0245%
$19.17$319,564+9.55%
2023-12-19SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
9,316
0.0133%
$19.13$178,215+6.29%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.